Feedback / Questions
YQ23 - New Beta Innovation
Keytruda (pembrolizumab) - Merck (MSD)
http://clinicaltrials.gov/ct2/show/NCT04513067
Dec 8, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next